Dr. Freeman on Challenges in Treatment Selection in Melanoma
Morganna Freeman, DO, associate director, Melanoma and Cutaneous Oncology Program, The Angeles Clinic and Research Institute, discusses the challenges associated with treatment selection in melanoma.
Disparities in Survival Outcomes Revealed With BluePrint and MammaPrint Subtyping in HR+/HER2– Breast Cancer
Dr Freeman on Mortality Differences Across Racial Groups in Male Patients With Breast Cancer
Dr Parsons on the Correlation Between Liquid Biopsy and HER2 Status in Breast Cancer
PFS Benefit Observed With Tucatinib Plus T-DM1 in Previously Treated HER2+ Metastatic Breast Cancer
2 Clarke Drive Cranbury, NJ 08512